Table 4.
Concomitant medications during study treatment.
Concomitant drug | Patients consuming the drug (n) |
---|---|
OMEPRAZOLO | 4 |
LEVOTIROXINA | 5 |
AMLODIPINA | 5 |
ESOMEPRAZOLO | 3 |
LANSOPRAZOLO | 1 |
OLMESARTAN | 2 |
ZOFENOPRIL | 1 |
IDROCLORTIAZIDE | 3 |
GLICLAZIDE | 1 |
PARACETAMOLO | 2 |
CODEINA | 1 |
PERINDROPIL | 2 |
SITAGLIPTIN | 1 |
METFORMINA | 1 |
DENOSUMAB | 2 |
LOSARTAN | 2 |
RANITIDINA | 1 |
NADROPARINA | 1 |
NEBIVOLOLO | 2 |
DOXAZOSINA | 2 |
FENOFIBRATO | 1 |
COLECALCIFEROLO | 1 |
ACIDO ACETIL SALICILICO | 1 |
LECARNEDIPINA | 2 |
FUROSEMIDE | 2 |
SILODOSINA | 1 |
VALSARTAN | 1 |
SIMVASTATINA | 1 |
LIOTIRONINA | 1 |
ALLOPURINOLO | 1 |
INDAPAMIDE | 1 |
ENOXAPARINA | 1 |
CANDESARTAN | 1 |
TORASEMIDE | 1 |
PANTOPRAZOLO | 1 |
RIVAROXABAR | 1 |
TAPENTADOL | 1 |
PREGABALIN | 1 |
LOPERAMIDE | 3 |
DICLOFENAC | 1 |
CEFTRIAXONE | 1 |
PARNAPARINA | 1 |
WARFARIN | 1 |